Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01598142
Other study ID # YLS2011-105
Secondary ID
Status Completed
Phase N/A
First received November 1, 2011
Last updated May 14, 2012
Start date October 2007
Est. completion date February 2011

Study information

Verified date May 2012
Source Zhejiang University
Contact n/a
Is FDA regulated No
Health authority China: Ministry of Health
Study type Interventional

Clinical Trial Summary

The single-operator wire-guided cannulation technique doesn't require an experienced assistant and precise coordination between the assistant and endoscopist.


Description:

A new single-operator wire-guided cannulation technique was performed on all patients. All procedures were performed by the same experienced endoscopist, but with different assistants in two groups (with an experienced one in Group A, and a new trained one in Group B). The number of attempts at cannulation, cannulation time, success rate, and procedure-related complications were compared between the two groups.


Recruitment information / eligibility

Status Completed
Enrollment 465
Est. completion date February 2011
Est. primary completion date December 2010
Accepts healthy volunteers No
Gender Both
Age group 14 Years and older
Eligibility Inclusion Criteria:

- hospitalized patients with pancreas and biliary diseases referred to the authors for ERCP

Exclusion Criteria:

- previous endoscopic sphincterotomy,

- surgically altered anatomy (e.g. Billroth II gastrectomy) or

- diagnostic duodenoscopy

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Intervention

Procedure:
Team 1
experienced endoscopist with a experienced assistant
Team 2
same experienced endoscopist with a new trained assistant

Locations

Country Name City State
China The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Qi-yong Li

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cannulation success rate two years Yes
Secondary Incidences of post-ERCP pancreatitis two years Yes
Secondary Incidences of bleeding two years Yes
Secondary Incidences of perforation two years Yes
Secondary Incidences of infection two years Yes
Secondary Number of attempts at cannulation two years Yes
Secondary Cannulation time two years Yes